Literature DB >> 23867008

Comparison of use of vaginal HPV self-sampling and offering flexible appointments as strategies to reach long-term non-attending women in organized cervical screening.

Lotten Darlin1, Christer Borgfeldt, Ola Forslund, Emir Hénic, Maria Hortlund, Joakim Dillner, Päivi Kannisto.   

Abstract

BACKGROUND: Many cervical cancers occur among women who have not attended cervical screening. Strategies to reach non-attending women may improve the effectiveness of cervical screening programmes.
OBJECTIVE: To compare the responses among long-term non-attending women to either (i) HPV-testing of a self-collected vaginal sample, or (ii) cytological screening with a flexible no-fee appointment for sampling at an outpatient clinic. STUDY
DESIGN: Among the 242,000 women aged 32-65 years in Southern Sweden, we identified 28,635 women who had not had any cervical smears taken for >9 years. We randomized 1000 women to invitation to HPV self-sampling, and 500 women to flexible outpatient clinic appointments. Responding women received a questionnaire about their reasons for previous non-attendance.
RESULTS: The response rate to HPV self-sampling was three times higher than the flexible outpatient clinic invitations (147/1000 women (14.7%) compared to 21/500 (4.2%) p<0.0001). High-risk (hr)-HPV was found in 10/147 self-sampled women (6.9%). 7/10 hr-HPV-positive women attended colposcopy, but no HSIL was found. Among the clinic-sampled women, 2/21 had hr-HPV and 1/21 had HSIL. Reasons for not attending were "uncomfortable with vaginal examination", "feel healthy", "lack of time" and "experience of unfriendly health workers".
CONCLUSIONS: Although the response rate was low for both interventions, the invitation to vaginal HPV self-sampling was more effective for increasing the coverage of the screening programme. The fact that "uncomfortable with vaginal examination" was the most common reason for non-attending suggests that self-sampling could be further explored as a strategy to increase the coverage of cervical screening programmes.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cytology; HPV testing; Non-attendance; Screening; Self-collected vaginal smear; Vaginal smear

Mesh:

Year:  2013        PMID: 23867008     DOI: 10.1016/j.jcv.2013.06.029

Source DB:  PubMed          Journal:  J Clin Virol        ISSN: 1386-6532            Impact factor:   3.168


  26 in total

1.  Reactions of women underscreened for cervical cancer who received unsolicited human papillomavirus self-sampling kits.

Authors:  Colin Malone; Jasmin A Tiro; Diana Sm Buist; Tara Beatty; John Lin; Kilian Kimbel; Hongyuan Gao; Chris Thayer; Diana L Miglioretti; Rachel L Winer
Journal:  J Med Screen       Date:  2019-11-20       Impact factor: 2.136

2.  Mailed Human Papillomavirus Self-Collection With Papanicolaou Test Referral for Infrequently Screened Women in the United States.

Authors:  Jennifer S Smith; Andrea C Des Marais; Allison M Deal; Alice R Richman; Carolina Perez-Heydrich; Belinda Yen-Lieberman; Lynn Barclay; Jerome Belinson; Allen Rinas; Noel T Brewer
Journal:  Sex Transm Dis       Date:  2018-01       Impact factor: 2.830

3.  Acceptability and Feasibility of Human Papilloma Virus Self-Sampling for Cervical Cancer Screening.

Authors:  Kumar Ilangovan; Erin Kobetz; Tulay Koru-Sengul; Erin N Marcus; Brendaly Rodriguez; Yisel Alonzo; Olveen Carrasquillo
Journal:  J Womens Health (Larchmt)       Date:  2016-02-18       Impact factor: 2.681

4.  Addressing multilevel barriers to cervical cancer screening in Korean American women: A randomized trial of a community-based intervention.

Authors:  Carolyn Y Fang; Grace X Ma; Elizabeth A Handorf; Ziding Feng; Yin Tan; Joanne Rhee; Suzanne M Miller; Charles Kim; Han Seung Koh
Journal:  Cancer       Date:  2016-11-21       Impact factor: 6.860

5.  Predictors of Cervical Cancer Screening Among Infrequently Screened Women Completing Human Papillomavirus Self-Collection: My Body My Test-1.

Authors:  Cary Suzanne Lea; Carolina Perez-Heydrich; Andrea C Des Marais; Alice R Richman; Lynn Barclay; Noel T Brewer; Jennifer S Smith
Journal:  J Womens Health (Larchmt)       Date:  2019-03-15       Impact factor: 2.681

6.  Rationale and design of the HOME trial: A pragmatic randomized controlled trial of home-based human papillomavirus (HPV) self-sampling for increasing cervical cancer screening uptake and effectiveness in a U.S. healthcare system.

Authors:  Rachel L Winer; Jasmin A Tiro; Diana L Miglioretti; Chris Thayer; Tara Beatty; John Lin; Hongyuan Gao; Kilian Kimbel; Diana S M Buist
Journal:  Contemp Clin Trials       Date:  2017-11-04       Impact factor: 2.226

7.  A Randomized Comparison of Different Vaginal Self-sampling Devices and Urine for Human Papillomavirus Testing-Predictors 5.1.

Authors:  Louise Cadman; Caroline Reuter; Mark Jitlal; Michelle Kleeman; Janet Austin; Tony Hollingworth; Anna L Parberry; Lesley Ashdown-Barr; Deepali Patel; Belinda Nedjai; Attila T Lorincz; Jack Cuzick
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2021-01-29       Impact factor: 4.254

Review 8.  Interventions targeted at women to encourage the uptake of cervical screening.

Authors:  Helen Staley; Aslam Shiraz; Norman Shreeve; Andrew Bryant; Pierre Pl Martin-Hirsch; Ketankumar Gajjar
Journal:  Cochrane Database Syst Rev       Date:  2021-09-06

Review 9.  The Possible Effects on Socio-Economic Inequalities of Introducing HPV Testing as Primary Test in Cervical Cancer Screening Programs.

Authors:  Paolo Giorgi Rossi; Flavia Baldacchini; Guglielmo Ronco
Journal:  Front Oncol       Date:  2014-02-10       Impact factor: 6.244

10.  Vaginal self-sampling is a cost-effective way to increase participation in a cervical cancer screening programme: a randomised trial.

Authors:  K Haguenoer; S Sengchanh; C Gaudy-Graffin; J Boyard; R Fontenay; H Marret; A Goudeau; N Pigneaux de Laroche; E Rusch; B Giraudeau
Journal:  Br J Cancer       Date:  2014-09-23       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.